|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Acquisition-related recoveries (expenses) | |||||
| Gain (loss) on sale of assets | |||||
| Asset impairments | |||||
| Income (loss) from operations | |||||
| Transferable tax credits, net | |||||
| Excess insurance proceeds | |||||
| Income from cash grant | |||||
| Interest expense, net | |||||
| Other income, net | |||||
| Income (loss) before provision (benefit) for income taxes | |||||
| Provision (benefit) for income taxes | |||||
| Consolidated net income (loss) | |||||
| Preferred stock dividends | |||||
| Income (loss) attributable to common stockholders | |||||
| Income (loss) per share, basic (in Dollars per share) | |||||
| Income (loss) per share, diluted (in Dollars per share) | |||||
| Weighted-average shares outstanding, basic (in Shares) | |||||
| Weighted-average shares outstanding, diluted (in Shares) | |||||
Loading...